Coral Dermatitis.
Lause M, Mcintyre M 2nd, Trinidad J.
JAMA Dermatol. 2019 Jan 1;155(1):107. doi: 10.1001/jamadermatol.2018.3592.
Coral contact dermatitis.
Jefferson J, Thompson C, Hinshaw M, Rich P.
Dermatol Online J. 2015 Apr 16;21(4):13030/qt0nx9f55w.
Coral dermatitis.
Weedon D, Hart V, Beardmore G, Dickson P.
Australas J Dermatol. 1981 Dec;22(3):104-5. doi: 10.1111/j.1440-0960.1981.tb00037.x.
Sunscreens part 2: Regulation and safety.
Abdel Azim S, Bainvoll L, Vecerek N, DeLeo VA, Adler BL.
J Am Acad Dermatol. 2025 Apr;92(4):689-698. doi: 10.1016/j.jaad.2024.02.066. Epub 2024 May 20.
Cerebriform eruption related to acute coral dermatitis.
Dyson ME, Kimyai-Asadi A.
Dermatol Online J. 2022 Dec 15;28(6). doi: 10.5070/D328659730.
Acute coral contact dermatitis.
Miguel-Gomez L, Fonda-Pascual P.
CMAJ. 2016 Dec 6;188(17-18):1260. doi: 10.1503/cmaj.151370. Epub 2016 Aug 8.
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Simpson EL, Eichenfield LF, Alonso-Llamazares J, Draelos ZD, Ferris LK, Forman SB, Gooderham M, Gonzalez ME, Hebert AA, Kircik LH, Lomaga M, Moore A, Papp KA, Prajapati VH, Hanna D, Snyder S, Krupa D, Burnett P, Almaraz E, Higham RC, Chu DH, Berk DR.
JAMA Dermatol. 2024 Nov 1;160(11):1161-1170. doi: 10.1001/jamadermatol.2024.3121.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Zirwas MJ, Draelos ZD, DuBois J, Kircik LH, Moore AY, Stein Gold L, Alonso-Llamazares J, Bukhalo M, Bruce S, Eads K, Green LJ, Guenthner ST, Ferris LK, Forman SB, Kempers SE, Lain E, Lynde CW, Pariser DM, Toth DP, Yamauchi PS, Higham RC, Krupa D, Burnett P, Berk DR.
JAMA Dermatol. 2023 Jun 1;159(6):613-620. doi: 10.1001/jamadermatol.2023.0846.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Blauvelt A, Draelos ZD, Stein Gold L, Alonso-Llamazares J, Bhatia N, DuBois J, Forman SB, Gooderham M, Green L, Guenthner ST, Hebert AA, Lain E, Moore AY, Papp KA, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk DR, Chu DH.
J Am Acad Dermatol. 2024 May;90(5):986-993. doi: 10.1016/j.jaad.2023.12.065. Epub 2024 Jan 20.
Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3.
DiNardo JC, Downs CA.
J Cosmet Dermatol. 2018 Feb;17(1):15-19. doi: 10.1111/jocd.12449. Epub 2017 Oct 31.
